January 22, 2018 / 12:18 PM / in a year

BRIEF-European Medicines Agency Issues Orphan Drug Designation Positive Opinion for Omeros' OMS721

Jan 22 (Reuters) - Omeros Corp:

* EUROPEAN MEDICINES AGENCY ISSUES ORPHAN DRUG DESIGNATION POSITIVE OPINION FOR OMEROS’ OMS721 IN THE TREATMENT OF IGA NEPHROPATHY

* OMEROS CORP - EMA ALSO REVIEWING PRIORITY MEDICINES APPLICATION FOR DRUG IN IGAN

* OMEROS CORP - POSITIVE OPINION ISSUED BY COMP IS EXPECTED TO BE ADOPTED BY EUROPEAN COMMISSION AT ITS FEBRUARY MEETING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below